Court upholds dismissal of $200M Merck verdict against Gilead

(Reuters) — A U.S. appeals court on Wednesday affirmed a ruling that pharmaceutical company Merck & Co. dishonestly obtained patent rights and was not entitled to collect a $200 million infringement verdict it won against rival Gilead Sciences Inc.

from Business Insurance https://ift.tt/2Kjb5Zl